Effect of an exercise-based program"TCM Daoyin Prescription" for postsurgical non-small cell lung cancer:study protocol for a randomized controlled trial

Category Primary study
Registry of TrialsITMCTR
Year 2022
INTERVENTION: Control group:Routine drug therapy (including targeted drug therapy and traditional Chinese medicine therapy) and health education;TCM Daoyin Prescription group:Routine drug therapy (including targeted drug therapy and traditional Chinese medicine therapy) and health education + TCM Daoyin Prescription; CONDITION: non‐small cell lung cancer PRIMARY OUTCOME: cardiorespiratory fitness; INCLUSION CRITERIA: Inclusion criteria The eligible participants must meet the following criteria ?aged between 18 and 80 yearshistologically diagnosed with Stage I–IIIA NSCLC according to the 8th edition cancer staging manual of the American Joint Committeeon Cancer and had received surgical therapy; ?Karnofsky performance status of at least =60 at study entry,Neutrophil absolute value > 1.5×109/L, platelet count > 80×109/L, hemoglobin > 100g/L; Normal liver and kidney function and conscious; ?There was no physical disability ?can complete the TCM Daoyin Prescription and the subject has signed an informed consent.
Epistemonikos ID: 06a087bc3cdf0cf2c56c2cea136c464819bec228
First added on: Aug 26, 2024